journal article·2026-05

Unexpected synthesis and anticancer activity evaluation of a smart lysosome-targeted photosensitizer based on BODIPY

Wanyu Tang, Mengjie Zhao, Changjiang Gao, Lala Fu, Shuyun Wang, Donghui Qin, Yayang Tian, Xiaobo Wang

Dyes and Pigments· Volume 248
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
2. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
3. Smart molecular designs and applications of activatable organic photosensitizers10.1038/s41570-024-00662-7 ↗
4. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
5. An osmium-peroxo complex for photoactive therapy of hypoxic tumors10.1038/s41467-022-29969-z ↗
6. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer10.1002/anie.202112236 ↗
7. An open label, phase II trial of continuous low-irradiance photodynamic therapy (CLIPT) using verteporfin for the treatment of cutaneous breast cancer metastases
8. Unraveling the pivotal role of atropisomerism for cellular internalization10.1021/jacs.2c05844 ↗
9. Tuning photodynamic properties of BODIPY dyes, porphyrins' little sisters10.3390/molecules26144194 ↗
10. Conjugates of porphyrinoid-based photosensitizers with cytotoxic drugs: current progress and future directions toward selective photodynamic therapy10.1021/acs.jmedchem.1c01953 ↗
11. New photosensitizer design concept: polymerization enhanced photosensitization10.1016/j.chempr.2018.08.027 ↗
12. Platinum-based two-photon photosensitizer responsive to NIR light in tumor hypoxia microenvironment10.1021/acs.jmedchem.2c00141 ↗
13. Self-assembly-integrated tumor targeting and electron transfer programming towards boosting tumor type I photodynamic therapy10.1039/D4SC03008G ↗
14. Enhancing biosafety in photodynamic therapy: progress and perspectives10.1039/D5CS00054H ↗
15. BODIPYs in PDT: a journey through the most interesting molecules produced in the last 10 years10.3390/ijms231710198 ↗
16. Constructing heavy-atom-free photosensitizers for hypoxic tumor phototherapy based on donor-excited photoinduced electron-transfer-driven type-I and type-II mechanisms10.1021/acsami.4c02175 ↗
17. Optimizing photosensitizers with type I and type II ROS generation through modulating triplet lifetime and intersystem crossing efficiency10.1002/adfm.202414542 ↗
18. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
19. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
20. Synthesis and photodynamic activities of pyridine- or pyridinium-substituted aza-BODIPY photosensitizers10.1021/acs.jmedchem.4c01641 ↗
21. Supramolecular assembly boosting the phototherapy performances of BODIPYs
22. Recent developments in the design of new water-soluble boron dipyrromethenes and their applications: an updated review10.1021/acsabm.3c00289 ↗
23. A host–guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator10.1039/D2SC01469F ↗
24. Deciphering the intersystem crossing in near-infrared BODIPY photosensitizers for highly efficient photodynamic therapy10.1039/C8SC04840A ↗
25. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo10.1038/s42255-022-00591-z ↗
26. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy10.1038/s41467-019-09566-3 ↗
27. Precise molecular Engineering of multi-suborganelle targeted NIR type-I AIE photosensitizer and design of cell membrane-anchored anti‐tumor pyroptosis vaccine10.1002/adfm.202417979 ↗
28. Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy10.1039/D3CS00456B ↗
29. A mitochondria-localized iridium(III) photosensitizer for two-photon photodynamic immunotherapy against melanoma10.1039/D2SC06675K ↗
30. Optimizing mitochondrial-targeting groups of positively-charged BODIPY nanoparticles for enhanced photodynamic therapy10.1039/D4QM00725E ↗
31. Light-driven mitochondrion-to-nucleus DNA cascade fluorescence imaging and enhanced cancer cell photoablation10.1021/jacs.3c13095 ↗
32. Single-cell quantification of a highly biocompatible dinuclear iridium(III) complex for photocatalytic cancer therapy10.1002/anie.202202098 ↗
33. A self-assembled Ru-Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy10.1073/pnas.1912549116 ↗
34. Organelle-targeted small molecular photosensitizers for enhanced photodynamic therapy: a minireview for recent advances and potential applications10.1039/D5CC01642H ↗
35. From cell membrane to lysosome: arginine modification boosts the phototoxic index of zinc phthalocyanine for efficient bladder cancer treatment10.1016/j.dyepig.2025.113219 ↗
36. Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy10.1016/j.dyepig.2024.112039 ↗
37. A dual-targeting photosensitizer for simultaneous mitochondrial and lysosomal disruption in cancer and antibacterial photodynamic therapy10.1039/D5TB01345C ↗
38. A cancer cell and lysosome dual-targeted photosensitizer for fluorescence imaging and photodynamic therapy10.1016/j.dyepig.2023.111861 ↗
39. Recent advances in single fluorescent probes for monitoring dual organelles in two channels
40. A lysosome-localized thionaphthalimide as a potential heavy-atom-free photosensitizer for selective photodynamic therapy10.1016/j.dyepig.2020.108265 ↗
41. AIE-active lysosome-targeted fluorescent organic nanoparticles for leucine aminopeptidase-activatable fluorescent imaging and precision photodynamic therapy potential10.1016/j.dyepig.2023.111781 ↗
42. A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy10.1016/j.dyepig.2017.07.048 ↗
43. Near-infrared heptamethine cyanine photosensitizers with efficient singlet oxygen generation for anticancer photodynamic therapy
44. Enhancing cytotoxicity of a monofunctional platinum complex via a dual-DNA-damage approach10.1021/acs.inorgchem.9b02033 ↗